华兴证券报告称,虽然韩国业务表现强劲,但仍预测百威亚太2024年第四季度正常化EBITDA按年下降25.8%,下调百威亚太目标价至11.6港元,维持“买入”评级。
特别声明:以上内容(如有图片或视频亦包括在内)为自媒体平台“网易号”用户上传并发布,本平台仅提供信息存储服务。
Notice: The content above (including the pictures and videos if any) is uploaded and posted by a user of NetEase Hao, which is a social media platform and only provides information storage services.